A more recent advance is mtDNA base editing, which utilizes engineered deaminase enzymes (e.g., DddA-derived cytosine base editors) to catalyze CG to TA base conversions in double-stranded mtDNA without creating double-strand breaks
When you combine this mechanism with an oversized meal, you're setting yourself up for significant discomfort
Though both act on the incretin system, they represent distinctly different generations of peptide engineering semaglutide as a refined single-receptor GLP-1 agonist, and tirzepatide as a dual GLP-1/GIP receptor agonist
So it makes sense that there's been a rise in so-called 'natural GLP-1 supplements,' which promise (or heavily imply) that theyll deliver similar results that youd get from an injectable GLP-1 medication only in a more accessible, far less expensive oral supplement
Bone Health*
You can get many of the same benefits naturally, with fewer side effects and more sustainability